Want to see AU:ICR full AI Analyst Report?
Top Page
InteliCare Holdings Limited
(Sydney:ICR)
Select Model
Select Model
Rating:50Neutral
Price Target:
AU$0.03
▲(30.00% Upside)
Action:Reiterated
Date:09/06/26
The score is held back primarily by weak financial quality—large ongoing losses and persistent negative free cash flow despite strong revenue growth and improving balance sheet stability. Technicals are supportive with price above key moving averages and positive MACD, but momentum is near overbought. Valuation cannot be assessed due to missing P/E and dividend yield data.
Positive Factors
Revenue acceleration
The sharp increase in annual revenue indicates stronger commercial traction and growing customer demand. If this momentum persists, a larger revenue base could improve operating leverage, support investment in the platform, and strengthen the company’s market position over the next several quarters.
Negative Factors
Severe unprofitability
Negative gross profit and losses roughly matching the revenue base show that the business has not yet demonstrated viable unit economics. Until gross margins turn positive and operating losses narrow materially, revenue growth may not translate into durable earnings or financial self-sufficiency.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue acceleration
The sharp increase in annual revenue indicates stronger commercial traction and growing customer demand. If this momentum persists, a larger revenue base could improve operating leverage, support investment in the platform, and strengthen the company’s market position over the next several quarters.
Read all positive factors
InteliCare Holdings Limited (ICR) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$18.60M
Dividend YieldN/A
Average Volume (3M)653.96K
Price to Earnings (P/E)―
Beta (1Y)0.05
Revenue Growth113.42%
EPS Growth29.17%
CountryAU
Employees8
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)N/A
Shares Outstanding715,306,760
10 Day Avg. Volume1,235,961
30 Day Avg. Volume653,961
Financial Highlights & Ratios
PEG Ratio0.17
Price to Book (P/B)8.89
Price to Sales (P/S)5.36
P/FCF Ratio-9.21
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
InteliCare Holdings Limited Business Overview & Revenue Model
Company Description
Operating out of Leederville, Australia, Intelicare Holdings Limited was founded in 2016. The company is dedicated to supplying innovative predictive analytics solutions, delivered as a combined hardware and software package, primarily serving Aus...
How the Company Makes Money
null...
InteliCare Holdings Limited Financial Statement Overview
Summary
Income Statement
14
Very Negative
Balance Sheet
33
Negative
Cash Flow
18
Very Negative
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.04M | 956.74K | 280.29K | 404.35K | 429.85K |
| Gross Profit | -1.12M | -1.09M | -1.79M | -2.69M | -2.75M |
| EBITDA | -2.45M | -2.16M | -3.02M | -2.89M | -3.78M |
| Net Income | -2.10M | -2.24M | -2.26M | -3.00M | -3.93M |
Balance Sheet | |||||
| Total Assets | 3.34M | 1.02M | 1.52M | 2.48M | 2.88M |
| Cash, Cash Equivalents and Short-Term Investments | 2.73M | 410.53K | 834.20K | 1.94M | 2.27M |
| Total Debt | 524.82K | 716.62K | 612.39K | 726.57K | 18.25K |
| Total Liabilities | 2.11M | 1.86M | 1.69M | 1.53M | 1.34M |
| Stockholders Equity | 1.23M | -833.17K | -168.32K | 949.11K | 1.54M |
Cash Flow | |||||
| Free Cash Flow | -1.19M | -1.67M | -1.66M | -3.11M | -3.14M |
| Operating Cash Flow | -1.18M | -1.67M | -1.66M | -3.10M | -3.10M |
| Investing Cash Flow | -3.81K | -7.09K | 0.00 | -14.35K | -32.92K |
| Financing Cash Flow | 3.51M | 1.25M | 555.65K | 2.78M | 2.73M |
InteliCare Holdings Limited Technical Analysis
Positive
0.02
Price Trends
0.02
Positive
0.02
Negative
Market Momentum
<0.01
Negative
52.64
Neutral
-50.00
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:ICR, the sentiment is Positive. The current price of 0.02 is above the 20-day moving average (MA) of 0.02, above the 50-day MA of 0.02, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 52.64 is Neutral, neither overbought nor oversold. The STOCH value of -50.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:ICR.
InteliCare Holdings Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | AU$141.73M | 61.76 | 2.53% | ― | 26.61% | 41.67% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | AU$163.64M | -9.45 | -203.69% | ― | -1.53% | 28.29% | |
50 Neutral | AU$18.60M | ― | -578.72% | ― | 113.42% | 29.17% | |
49 Neutral | AU$35.44M | -1.91 | -58.13% | ― | 2.08% | -195.31% | |
48 Neutral | AU$47.67M | 19.23 | 90.90% | ― | 5.35% | ― | |
43 Neutral | AU$22.99M | -2.53 | -1688.04% | ― | 11.45% | 0.69% |
* Healthcare Sector Average
AU:ICR
InteliCare Holdings Limited
0.03
<0.01
52.94%
AU:ONE
Oneview Healthcare Chess Depository Interests repr 1
0.20
-0.03
-14.89%
AU:BMT
Beamtree Holdings Ltd
0.12
-0.12
-50.00%
AU:ALC
Alcidion Group Limited
0.11
0.02
16.67%
AU:PCK
PainChek Ltd
0.11
-0.33
-75.00%
AU:DOC
Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh
0.13
-0.05
-27.78%
InteliCare Holdings Limited Corporate Events
InteliCare Narrows Annual Loss and Turns Net Tangible Assets Positive
Aug 26, 2026
InteliCare Holdings Limited reported a reduced annual loss for the year ended 30 June 2026, with loss from ordinary activities after tax narrowing 6.5% to $2.10 million compared with the prior year. The company did not declare any dividends, and i...
InteliCare Says No Undisclosed News Behind Share Price Spike
Aug 25, 2026
InteliCare Holdings Ltd has responded to an Australian Securities Exchange price and volume query after its shares rose from $0.024 to an intraday high of $0.028 amid heavier trading. The company stated it is not aware of any undisclosed informati...
InteliCare lifts Hardi Aged Care contract value with Nurse Call rollout
Jul 27, 2026
InteliCare Holdings has expanded its commercial agreement with Hardi Aged Care, a private Western Sydney operator of six residential aged care facilities with about 580 beds, following an upgrade of Hardi’s Blacktown site and a broader rollo...
InteliCare updates capital structure and rectifies historical option lapse disclosure
Jul 23, 2026
InteliCare Holdings Limited, an Australian AI-powered care platform provider for the aged care and retirement living sectors, has detailed its issued capital position as at 30 June 2026, including more than 714 million fully paid ordinary shares a...
InteliCare Options Lapse, Removing Potential Share Dilution
Jul 23, 2026
InteliCare Holdings Limited has reported the lapse of a series of options over recent years, resulting in the cessation of more than 25 million unexercised securities across multiple option classes. These options, with various exercise prices and ...
InteliCare Highlights Digital Intelligence Strategy for Aged Care
Jun 16, 2026
InteliCare Holdings Limited has released an investor presentation outlining its role in using digital intelligence to transform aged care delivery. The company positions itself as a technology partner to aged care providers, highlighting its strat...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.